Health data and industry safety data modeling has become more complex and challenging. These models may involve data that must be addressed at the multiple layers, including at the community level where some of the individual-level data may not be available. Colleagues are encouraged to submit papers on various methods and/or new methodologies/applications of clinical study design, and modeling in COVID-19, cancer and other disease, industry safety data in translational research.
Key topics: Modelling, Safety data, Chronic disease, COVID19